Resource Logo

Intellectual property issues in a clinical trial: a corporate perspective.


Qual Assur. 1992 Jun;1(3):237-48. Unique Identifier : AIDSLINE

Acquired Immunodeficiency Syndrome/*THERAPY *Clinical Trials/LEGISLATION & JURISPRUD Confidentiality/LEGISLATION & JURISPRUD Conflict of Interest/LEGISLATION & JURISPRUD Drug Industry/*ORGANIZATION & ADMIN Financing, Government/LEGISLATION & JURISPRUD Health Policy/LEGISLATION & JURISPRUD Human *Interinstitutional Relations National Institutes of Health (U.S.)/*ORGANIZATION & ADMIN *Patents/LEGISLATION & JURISPRUD Research Support/LEGISLATION & JURISPRUD United States JOURNAL ARTICLE


Information in this article was accurate in July 30, 1994. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.